Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | CCND1 | P24385 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19386035 | 0.86 | NPC1 (0.47) | ALDH1A1SMN1; SMN2GAAMAPTMEN1 | |
| SCHEMBL6933770 | 0.85 | POLB (0.44) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL3892024 | 0.85 | ALDH1A1 (0.46) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL19403484 | 0.85 | HPGD (0.48) | ALDH1A1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL7049482 | 0.85 | SMN1; SMN2 (0.54) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL7867128 | 0.84 | FFAR1 (0.55) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL25470592 | 0.83 | ALDH1A1 (0.41) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL3901176 | 0.83 | ALDH1A1 (0.41) | ALDH1A1CCNB2CCNE2CDK1CDK4 | |
| SCHEMBL7868844 | 0.83 | HSP90AA1 (0.48) | ALDH1A1GAAKDM4EMAPTKMT2A | |
| SCHEMBL3901459 | 0.83 | NPC1 (0.42) | ALDH1A1CCNB2CCNE2CDK1CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-14 | — | — | US | disclosed |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-04-11 | — | — | US | disclosed |
| WO-2017164813-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2017-09-28 | — | — | WO | disclosed |
| US-20090264660-A1 | PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS | Kang, Heonjoong (KR) | 2009-10-22 | — | — | US | disclosed |
| US-20090264660-A1 | PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS | Kang, Heonjoong (KR) | 2009-10-22 | — | — | US | disclosed |
| EP-1924265-A2 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | Genzyme Corporation (US) | 2008-05-28 | — | — | EP | disclosed |
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
| WO-2007022371-A2 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORPORATION (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10710061-B2 | Ion pair catalysis of tungstate and molybdate | PRDX3, PRDX4, PRDX2 | ALDH1A1 1230/4885CCNB2 3158/4885CCNE2 2365/4885 |
| US-20190105646-A1 | ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE | PRDX3, PRDX4, PRDX6 | ALDH1A1 1492/4885CCNB2 3337/4885CCNE2 2811/4885 |
| US-20090264660-A1 | PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS | TST, ARSA, STS | ALDH1A1 210/4885CCNB2 2483/4885CCNE2 2302/4885 |
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | ALDH1A1 3484/4885CCNB2 2714/4885CCNE2 2462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.